Sugi Predict

Sugi Predict / Compounds / Iodomethane

Iodomethane

Iodomethane

SCHEMBL114985

CI.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.80
▸ CYP3A4 P08684 1/20 0.80
▸ ESR1 P03372 4/20 0.57
▸ ESR2 Q92731 4/20 0.57
▸ KDM4E B2RXH2 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ DRD1 P21728 2/20 0.38
▸ TSHR P16473 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ ACHE P22303 2/20 0.37
▸ ALOX12 P18054 2/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ HPGD P15428 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CA4 P22748 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ APOBEC3A P31941 1/20 0.30
▸ APOBEC3G Q9HC16 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5028587 0.89 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL101 0.89 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
Benzene SCHEMBL6890099 0.89 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL2085135 0.89 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL11498882 0.87 TDP1 (0.80) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL21296017 0.87 TDP1 (0.80) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL22023055 0.87 TDP1 (0.80) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL21296015 0.87 TDP1 (0.80) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL1930070 0.87 TDP1 (0.80) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL21084295 0.87 TDP1 (0.80) TDP1CYP3A4ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 347 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119930444-A Ozone resisting agent for rubber, preparation method and application thereof, and rubber 株洲时代新材料科技股份有限公司 2025-05-06 — — CN claimed
CN-119285533-A Preparation method of key intermediate of lysine-specific demethylase 1 (LSD 1) inhibitor 江苏联环药业股份有限公司 2025-01-10 — — CN claimed
CN-119080864-A Preparation method and application of etonogestrel intermediate 上海格苓凯生物科技有限公司 2024-12-06 — — CN claimed
CN-113880694-B Synthesis method of hydroxy-substituted styrene compound and synthesis method of photoresist resin monomer 徐州博康信息化学品有限公司 2024-09-13 — — CN claimed
CN-117069555-A Synthetic method of substituted phenol 西安文理学院 2023-11-17 — — CN claimed
CN-115160202-B Preparation method of carboprost tromethamine and intermediate thereof 广州楷石医药有限公司 2023-10-31 — — CN claimed
CN-116837486-A Ultraviolet-resistant extinction cationic polyester fiber 江苏轩达高分子材料有限公司 2023-10-03 — — CN claimed
CN-114534782-B Porous organic ion polymer, single-atom Rh-loaded catalyst and preparation method and application thereof 中国科学院大连化学物理研究所 2023-08-08 — — CN claimed
WO-2023135499-A1 PROCESS FOR ROXADUSTAT USING NOVEL INTERMEDIATES OPTIMUS DRUGS PVT LTD (IN) 2023-07-20 — — WO claimed
CN-112457440-B Boron functionalized o-carborane-styrene polymer and preparation method thereof 西南科技大学 2023-03-24 — — CN claimed
CN-103086848-B Dicyclohexylalkyl ether terminal olefines liquid crystal compound and preparation method thereof YANTAI DERUN LIQUID CRYSTAL MATERIALS CO LTD 2014-09-03 — — CN claimed
WO-2014037873-A1 PROCESS FOR PREPARING 11 -METHYLENE-18-METHYL-ESTR-4-EN-3, 17- DIONE, USEFUL AS INTERMEDIATE COMPOUND FOR THE SYNTHESIS OF MOLECULES HAVING A PHARMACOLOGICAL ACTIVITY INDUSTRIALE CHIMICA S.R.L. (IT) 2014-03-13 — — WO claimed
US-20130165696-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2013-06-27 — — US claimed
EP-2588441-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR Actavis Group Ptc Ehf (IS) 2013-05-08 — — EP claimed
CN-103086848-A Dicyclohexylalkyl ether terminal olefines liquid crystal compound and preparation method thereof YANTAI DERUN LIQUID CRYSTAL MATERIALS CO LTD 2013-05-08 — — CN claimed
EP-2534127-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN Laboratories Limited (IN) 2012-12-19 — — EP claimed
WO-2012001531-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2012-01-05 — — WO claimed
CN-102180846-A Resveratrol dimer derivative and preparation and application methods thereof UNIV SHANGHAI JIAOTONG 2011-09-14 — — CN claimed
WO-2011099033-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN LABORATORIES LIMITED (IN) 2011-08-18 — — WO claimed
CN-1612056-A Hydrazone charge transmitting material, and its preparing method and use CHEMISTRY INST CHINESE AEADEMY (CN) 2005-05-04 — — CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165696-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR THPO, P2RY4, TBXA2R TDP1 1304/4885CYP3A4 28/4885ESR1 4604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.